← All Startups
Obsidian Therapeutics Series C
Cell and gene therapies
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Location
Cambridge, MA
Website
obsidiantx.com
LinkedIn
View profile
Founders
Vic Myer ’89
Jeffrey Trigilio ’06
BiotechnologyHealth CarePharmaceutical
Similar Startups
Boundless Bio
Precision oncology therapeutic
Paul Mischel, MD ’91
Series C
Headway
Mental healthcare
Jake Sussman ’13
Series D
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11
Moderna
mRNA vaccines
Robert Langer ’70
Pyxis Oncology
Oncology medicine portfolio
Lara Sullivan ’94
AKASA
Generative AI solutions for the healthcare revenue cycle
Malinka Walaliyadde ’12
Series C